Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis.

Baerlocher, Gabriela M.; Burington, Bart; Snyder, David S (2015). Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis. New England journal of medicine NEJM, 373(26), p. 2580. Massachusetts Medical Society MMS 10.1056/NEJMc1512663

[img]
Preview
Text
GMB_Telomerase_NEJMc1512663.pdf - Published Version
Available under License Publisher holds Copyright.

Download (342kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)

UniBE Contributor:

Baerlocher, Gabriela M.

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0028-4793

Publisher:

Massachusetts Medical Society MMS

Language:

English

Submitter:

Verena Zwahlen

Date Deposited:

23 Mar 2016 10:31

Last Modified:

16 Jul 2018 15:13

Publisher DOI:

10.1056/NEJMc1512663

PubMed ID:

26699176

BORIS DOI:

10.7892/boris.80204

URI:

https://boris.unibe.ch/id/eprint/80204

Actions (login required)

Edit item Edit item
Provide Feedback